'Making America Healthy Again' Must Start With Better Drug Policy | Opinion
The Trump-Vance administration has the opportunity to take decisive action to curb the devastating effects of drug ...
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Could Cutting DEI In Medicine Cost Lives? The High-Stakes Impact Of Trump’s Executive Order
With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation ...
JD Supra1d
Trump Administration’s DEI Executive Order and the Impact on FDA’s DAP Draft Guidance: Top Points
For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, ...